Mutual Fund Ownership
Ownership as on: Sun, 25 Feb, 2024

Quant Value Fund Regular Growth

NA
Equity
Amount Invested (Cr.)34.94
% of AUM3.13%

Aditya Birla Sun Life Manufacturing Equity Fund Regular Plan Growth

NA
Equity
Amount Invested (Cr.)21.66
% of AUM2.56%

Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)14.19
% of AUM2.19%

Aditya Birla Sun Life Pure Value Fund Growth

3/5
Equity
Amount Invested (Cr.)106.34
% of AUM1.87%

Aditya Birla Sun Life Retirement Fund - The 30s Pln Regular Growth

NA
Solutions Oriented
Amount Invested (Cr.)5.39
% of AUM1.52%

FAQs about Strides Pharma Science share price

Strides Pharma Science is trading at 802.35 as on Fri Feb 23 2024 09:59:06. This is -0.59% lower as compared to its previous closing price of 807.10.

The market capitalization of Strides Pharma Science is 7373.57 Cr as on Fri Feb 23 2024 09:59:06.

The average broker rating on Strides Pharma Science is Buy. The breakup of analyst rating is given below -

  • 0 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 0 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Strides Pharma Science is 838.10 whereas the 52 wk low is 268.40

Strides Pharma Science can be analyzed on the following key metrics -

  • TTM P/E: -
  • Sector P/E: 22.05
  • Dividend Yield: 0.19%
  • D/E ratio: -

Strides Pharma Science reported a net profit of -202.63 Cr in 2023.

Recommended For You
Images
Trending Stocks
1,616.50+22.75(1.43%)
1,930.20+21.60(1.13%)
3,691.25+39.45(1.08%)
1,665.70-21.05 (-1.25%)
11,539.15-136.35 (-1.17%)